Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
October-2025 Volume 32 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2025 Volume 32 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived ε‑viniferin in human endometrial cells: 
A potential therapy for endometriosis

  • Authors:
    • Yinzhi Lin
    • Yoshikazu Naiki
    • Shiori Kojima
    • Masatoshi Hakamata
    • Hitomi Fukatsu
    • Yoshiaki Hasegawa
    • Akihiko Wakatsuki
    • Naoki Koide
    • Kazuo Umezawa
  • View Affiliations / Copyright

    Affiliations: Department of Molecular Target Medicine, Aichi Medical University, Nagakute, Aichi 480‑1195, Japan, Department of Microbiology, School of Dentistry, Aichi Gakuin University, Nagoya, Aichi 464‑8650, Japan, Fukuyu Medical Institute, Fukuyu Medical Corporation, Nisshin, Aichi 470‑0103, Japan, Department of Obstetrics and Gynecology, Aichi Medical University, Nagakute, Aichi 480‑1195, Japan, Department of Microbiology and Immunology, Aichi Medical University, Nagakute, Aichi 480‑1195, Japan
    Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 283
    |
    Published online on: August 7, 2025
       https://doi.org/10.3892/mmr.2025.13648
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Endometriosis is a chronic gynecological disorder characterized by the ectopic growth and proliferation of endometrial tissue outside the uterine cavity, leading to inflammation. Although low‑dose contraceptive pills are widely used for its treatment, these therapies are associated with side effects and are contraindicated in women trying to conceive. ε‑viniferin is a resveratrol dimer found in wild grapes (Ampelopsis brevipedunculata) with demonstrated antioxidant properties and an anti‑migratory effect in lung cancer cells. Because abnormal cell migration is a key process in endometriosis, we hypothesized that ε‑viniferin could also exhibit anti‑migratory effects in endometriotic cells, which remain to be elucidated. To test this hypothesis, the present study investigated the anti‑inflammatory and anti‑endometriotic effects of ε‑viniferin and wild‑grape extract. RAW264.7 and THP‑1 were used to evaluate the anti‑inflammatory effects of wild‑grape extract and ε‑viniferin by assessing cytotoxicity; nitric oxide (NO), reactive oxygen species and interleukin‑6 (IL‑6) production; and NF‑κB activity. Additionally, human endometrial stromal cells (HESCs) were used to investigate the anti‑endometriotic effects of ε‑viniferin, including its impact on cell migration, invasion and gene expression, using PCR array analysis. Both ε‑viniferin and wild‑grape extract significantly reduced lipopolysaccharide‑induced NO and IL‑6 production, indicating an anti‑inflammatory activity. Inhibition of NF‑κB activity at the cellular level further supported these findings. Moreover, both ε‑viniferin and wild‑grape extract effectively suppressed the migration and invasion of HESCs, indicating their potential to alleviate endometriosis symptoms. These findings suggest that ε‑viniferin is a promising therapeutic candidate for endometriosis, exhibiting both anti‑inflammatory and anti‑migratory effects. Our results present a novel approach for developing effective anti‑endometriotic therapies.
View Figures

Figure 1

Chemical structure of
ε-viniferin.

Figure 2

Inhibition of inflammatory regulators
and ROS production by wild-grape extract in RAW264.7 cells.
(A) Effect of wild-grape extract on cell viability after 24 h of
exposure, assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5
diphenyl tetrazolium bromide (MTT) assay. (B) Inhibition of
LPS-induced NO production. (C) Reduction of LPS-induced ROS
production, measured based on fluorescent intensity. (D) In
vitro antioxidant activity determined using the DPPH
radical-scavenging assay. (E) Effect on LPS-induced expression of
iNOS, IL-6 and IL-1β. (F) Inhibition of LPS-induced IL-6
expression. (G) Inhibition of LPS-induced IL-6 secretion. RAW264.7
cells were stimulated with 100 ng/ml LPS in the presence or absence
of wild-grape extract. n=3. *P<0.05, **P<0.01, ***P<0.001
vs. control without the extract. LPS, lipopolysaccharide; NO,
nitric oxide; ROS, reactive oxygen species; DPPH,
2,2-diphenyl-1-picrylhydrazyl; iNOS, inducible NOS; IL,
interleukin; mGapdh, mouse glyceraldehyde-3-phosphate
dehydrogenase.

Figure 3

Inhibition of inflammatory regulator
production and NF-κB activity by ε-viniferin in RAW264.7 cells. (A)
Effect of ε-viniferin on cell viability after 24 h of exposure. (B)
In vitro antioxidant activity determined using the DPPH
radical-scavenging assay. (C) Inhibition of LPS-induced NO
production. (D) Inhibition of LPS-induced ROS production, measured
based on fluorescent intensity. (E) Effect of ε-viniferin on cell
viability after 4 h of exposure. (F) Inhibition of LPS-induced IL-6
expression. (G) Inhibition of LPS-induced IL-6 secretion. (H)
Inhibition of LPS-induced NF-κB activity. RAW264.7 cells were
stimulated with 100 ng/ml LPS in the presence or absence of
ε-viniferin. N=3. *P<0.05, **P<0.01, ***P<0.001 vs.
control without ε-viniferin and LPS. LPS, lipopolysaccharide; NO,
nitric oxide; ROS, reactive oxygen species; IL, interleukin; DPPH,
2,2-diphenyl-1-picrylhydrazyl; mGapdh, mouse
glyceraldehyde-3-phosphate dehydrogenase.

Figure 4

Inhibition of IL-6 expression and
secretion by ε-viniferin in THP-1 cells. (A) Effect of ε-viniferin
on cell viability after 4 h of exposure. (B) Inhibition of
LPS-induced IL-6 expression. (C) Inhibition of LPS-induced IL-6
secretion. THP-1 cells were stimulated with 100 ng/ml LPS in the
presence or absence of ε-viniferin. N=3. *P<0.05, **P<0.01,
***P<0.001 vs. control without ε-viniferin and LPS. IL,
interleukin; LPS, lipopolysaccharide. ACTB, β-actin.

Figure 5

Inhibition of migration and invasion
of human endometrial stromal cells by ε-viniferin. (A) Effect of
ε-viniferin on cell viability after 24 h of exposure. (B)
Inhibition of cell migration assessed using the wound healing assay
after 8 h of treatment. (C) Suppression of cell invasion measured
using the Matrigel invasion chamber assay after 16 h of treatment.
Magnification, ×100. N=3. **P<0.01, ***P<0.001 vs. control
without ε-viniferin.
View References

1 

Zondervan KT, Becker CM and Missmer SA: Endometriosis. N Engl J Med. 382:1244–1256. 2020. View Article : Google Scholar : PubMed/NCBI

2 

Pessoa de Farias Rodrigues M, Lima Vilarino F, de Souza Barbeiro Munhoz A, da Silva Paiva L, de Alcantara Sousa LV, Zaia V and Parente Barbosa C: Clinical aspects and the quality of life among women with endometriosis and infertility: A cross-sectional study. BMC Womens Health. 20:1242020. View Article : Google Scholar : PubMed/NCBI

3 

Johnson NP and Hummelshoj L; World Endometriosis Society Montpellier Consortium, : Consensus on current management of endometriosis. Hum Reprod. 28:1552–1568. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Taylor HS, Kotlyar AM and Flores VA: Endometriosis is a chronic systemic disease: Clinical challenges and novel innovations. Lancet. 397:839–852. 2021. View Article : Google Scholar : PubMed/NCBI

5 

Hee L, Kettner LO and Vejtorp M: Continuous use of oral contraceptives: An overview of effects and side-effects. Acta Obstet Gynecol Scand. 92:125–136. 2013. View Article : Google Scholar : PubMed/NCBI

6 

De Corte P, Milhoranca I, Mechsner S, Oberg AS, Kurth T and Heinemann K: Unravelling the causal relationship between endometriosis and the risk for developing venous thromboembolism: A pooled analysis. Thromb Haemost. 125:385–394. 2025. View Article : Google Scholar : PubMed/NCBI

7 

Polyzos NP, Fatemi HM, Zavos A, Grimbizis G, Kyrou D, Velasco JG, Devroey P, Tarlatzis B and Papanikolaou EG: Aromatase inhibitors in post-menopausal endometriosis. Reprod Biol Endocrinol. 9:902011. View Article : Google Scholar : PubMed/NCBI

8 

Pavone ME and Bulun SE: Clinical review: The use of aromatase inhibitors for ovulation induction and superovulation. J Clin Endocrinol Metab. 98:1838–1844. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Takagi H, Takakura M and Sasagawa T: Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest. Taiwan J Obstet Gynecol. 62:852–857. 2023. View Article : Google Scholar : PubMed/NCBI

10 

Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E and Brophy JM: Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. BMJ. 357:j19092017. View Article : Google Scholar : PubMed/NCBI

11 

Hägg S, Jönsson AK and Ahlner J: Current evidence on abuse and misuse of gabapentinoids. Drug Saf. 43:1235–1254. 2020. View Article : Google Scholar : PubMed/NCBI

12 

Rahmioglu N, Nyholt DR, Morris AP, Missmer SA, Montgomery GW and Zondervan KT: Genetic variants underlying risk of endometriosis: Insights from meta-analysis of eight genome-wide association and replication datasets. Hum Reprod Update. 20:702–716. 2014. View Article : Google Scholar : PubMed/NCBI

13 

Nishimoto-Kakiuchi A, Sato I, Nakano K, Ohmori H, Kayukawa Y, Tanimura H, Yamamoto S, Sakamoto Y, Nakamura G, Maeda A, et al: A long-acting anti-IL-8 antibody improves inflammation and fibrosis in endometriosis. Sci Transl Med. 15:eabq58582023. View Article : Google Scholar : PubMed/NCBI

14 

Yoshino O, Yamada-Nomoto K, Kobayashi M, Andoh T, Hongo M, Ono Y, Hasegawa-Idemitsu A, Sakai A, Osuga Y and Saito S: Bradykinin system is involved in endometriosis-related pain through endothelin-1 production. Eur J Pain. 22:501–510. 2018. View Article : Google Scholar : PubMed/NCBI

15 

Bruner-Tran KL, Osteen KG, Taylor HS, Sokalska A, Haines K and Duleba AJ: Resveratrol inhibits development of experimental endometriosis in vivo and reduces endometrial stromal cell invasiveness in vitro. Biol Reprod. 84:106–112. 2011. View Article : Google Scholar : PubMed/NCBI

16 

Ricci AG, Olivares CN, Bilotas MA, Bastón JI, Singla JJ, Meresman GF and Barañao RI: Natural therapies assessment for the treatment of endometriosis. Hum Reprod. 28:178–188. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Rudzitis-Auth J, Menger MD and Laschke MW: Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis. Hum Reprod. 28:1339–1347. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Zghonda N, Yoshida S, Araki M, Kusunoki M, Mliki A, Ghorbel A and Miyazaki H: Greater effectiveness of ε-viniferin in red wine than its monomer resveratrol for inhibiting vascular smooth muscle cell proliferation and migration. Biosci Biotechnol Biochem. 75:1259–1267. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Courtois A, Atgié C, Marchal A, Hornedo-Ortega R, Lapèze C, Faure C, Richard T and Krisa S: Tissular distribution and metabolism of trans-ε-viniferin after intraperitoneal injection in rat. Nutrients. 10:16602018. View Article : Google Scholar : PubMed/NCBI

20 

Kim J, Min JS, Kim D, Zheng YF, Mailar K, Choi WJ, Lee C and Bae SK: A simple and sensitive liquid chromatography-tandem mass spectrometry method for trans-ε-viniferin quantification in mouse plasma and its application to a pharmacokinetic study in mice. J Pharm Biomed Anal. 134:116–121. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Jiménez-Moreno N, Volpe F, Moler JA, Esparza I and Ancín-Azpilicueta C: Impact of extraction conditions on the phenolic composition and antioxidant capacity of grape stem extracts. Antioxidants (Basel). 8:5972019. View Article : Google Scholar : PubMed/NCBI

22 

Sergi D, Gélinas A, Beaulieu J, Renaud J, Tardif-Pellerin E, Guillard J and Martinoli MG: Anti-apoptotic and anti-inflammatory role of trans ε-viniferin in a neuron-glia co-culture cellular model of Parkinson's disease. Foods. 10:5862021. View Article : Google Scholar : PubMed/NCBI

23 

Beaumont P, Amintas S, Krisa S, Courtois A, Richard T, Eseberri I and Portillo MP: Glucuronide metabolites of trans-ε-viniferin decrease triglycerides accumulation in an in vitro model of hepatic steatosis. J Physiol Biochem. 80:685–696. 2024. View Article : Google Scholar : PubMed/NCBI

24 

Huang C, Lin ZJ, Chen JC, Zheng HJ, Lai YH and Huang HC: α-viniferin-induced apoptosis through downregulation of SIRT1 in non-small cell lung cancer cells. Pharmaceuticals (Basel). 16:7272023. View Article : Google Scholar : PubMed/NCBI

25 

Zhang S, Ma Y and Feng J: Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: Significance of SIRT3-mediated FOXO3 deacetylation. Neural Regen Res. 15:2143–2153. 2020. View Article : Google Scholar : PubMed/NCBI

26 

Gómez-Zorita S, Milton-Laskibar I, Eseberri I, Beaumont P, Courtois A, Krisa S and Portillo MP: Beneficial effects of ε-viniferin on obesity and related health alterations. Nutrients. 15:9282023. View Article : Google Scholar : PubMed/NCBI

27 

Chiou WC, Huang C, Lin ZJ, Hong LS, Lai YH, Chen JC and Huang HC: α-viniferin and ε-viniferin inhibited TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in lung cancer cells through downregulation of vimentin expression. Nutrients. 14:22942022. View Article : Google Scholar : PubMed/NCBI

28 

Soni UK, Chadchan SB, Kumar V, Ubba V, Khan MTA, Vinod BSV, Konwar R, Bora HK, Rath SK, Sharma S and Jha RK: A high level of TGF-B1 promotes endometriosis development via cell migration, adhesiveness, colonization, and invasiveness†. Biol Reprod. 100:917–938. 2019. View Article : Google Scholar : PubMed/NCBI

29 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

30 

Szewczuk LM, Lee SH, Blair IA and Penning TM: Viniferin formation by COX-1: Evidence for radical intermediates during co-oxidation of resveratrol. J Nat Prod. 68:36–42. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Privat C, Telo JP, Bernardes-Genisson V, Vieira A, Souchard JP and Nepveu F: Antioxidant properties of trans-ε-viniferin as compared to stilbene derivatives in aqueous and nonaqueous media. J Agric Food Chem. 50:1213–1217. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Lin Y, Kojima S, Ishikawa A, Matsushita H, Takeuchi Y, Mori Y, Ma J, Takeuchi K, Umezawa K and Wakatsuki A: Inhibition of MLCK-mediated migration and invasion in human endometriosis stromal cells by NF-κB inhibitor DHMEQ. Mol Med Rep. 28:1412023. View Article : Google Scholar : PubMed/NCBI

33 

Maia H Jr, Haddad C, Pinheiro N and Casoy J: Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain. Int J Womens Health. 4:543–549. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lin Y, Naiki Y, Kojima S, Hakamata M, Fukatsu H, Hasegawa Y, Wakatsuki A, Koide N and Umezawa K: Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis. Mol Med Rep 32: 283, 2025.
APA
Lin, Y., Naiki, Y., Kojima, S., Hakamata, M., Fukatsu, H., Hasegawa, Y. ... Umezawa, K. (2025). Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis. Molecular Medicine Reports, 32, 283. https://doi.org/10.3892/mmr.2025.13648
MLA
Lin, Y., Naiki, Y., Kojima, S., Hakamata, M., Fukatsu, H., Hasegawa, Y., Wakatsuki, A., Koide, N., Umezawa, K."Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis". Molecular Medicine Reports 32.4 (2025): 283.
Chicago
Lin, Y., Naiki, Y., Kojima, S., Hakamata, M., Fukatsu, H., Hasegawa, Y., Wakatsuki, A., Koide, N., Umezawa, K."Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis". Molecular Medicine Reports 32, no. 4 (2025): 283. https://doi.org/10.3892/mmr.2025.13648
Copy and paste a formatted citation
x
Spandidos Publications style
Lin Y, Naiki Y, Kojima S, Hakamata M, Fukatsu H, Hasegawa Y, Wakatsuki A, Koide N and Umezawa K: Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis. Mol Med Rep 32: 283, 2025.
APA
Lin, Y., Naiki, Y., Kojima, S., Hakamata, M., Fukatsu, H., Hasegawa, Y. ... Umezawa, K. (2025). Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis. Molecular Medicine Reports, 32, 283. https://doi.org/10.3892/mmr.2025.13648
MLA
Lin, Y., Naiki, Y., Kojima, S., Hakamata, M., Fukatsu, H., Hasegawa, Y., Wakatsuki, A., Koide, N., Umezawa, K."Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis". Molecular Medicine Reports 32.4 (2025): 283.
Chicago
Lin, Y., Naiki, Y., Kojima, S., Hakamata, M., Fukatsu, H., Hasegawa, Y., Wakatsuki, A., Koide, N., Umezawa, K."Anti‑inflammatory and anti‑migratory properties of wild‑grape‑derived &epsilon;‑viniferin in human endometrial cells:&nbsp;<br />A potential therapy for endometriosis". Molecular Medicine Reports 32, no. 4 (2025): 283. https://doi.org/10.3892/mmr.2025.13648
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team